Nitroglycerin: Rapid-Acting Angina Relief and Prevention
| Product dosage: 2.5mg | |||
|---|---|---|---|
| Package (num) | Per cap | Price | Buy |
| 30 | $2.32 | $69.52 (0%) | 🛒 Add to cart |
| 60 | $1.86 | $139.04 $111.84 (20%) | 🛒 Add to cart |
| 90 | $1.70 | $208.56 $153.15 (27%) | 🛒 Add to cart |
| 120 | $1.63 | $278.08 $195.46 (30%) | 🛒 Add to cart |
| 180 | $1.55 | $417.12 $279.09 (33%) | 🛒 Add to cart |
| 270 | $1.50 | $625.68 $405.03 (35%) | 🛒 Add to cart |
| 360 | $1.47
Best per cap | $834.25 $529.97 (36%) | 🛒 Add to cart |
Nitroglycerin is a cornerstone medication in the management of angina pectoris, a condition characterized by chest pain due to myocardial ischemia. As an organic nitrate vasodilator, its primary mechanism of action involves the relaxation of vascular smooth muscle, leading to venous and arterial dilation. This reduces cardiac preload and afterload, thereby decreasing myocardial oxygen demand and improving coronary blood flow to ischemic areas. Available in sublingual tablets, sprays, ointments, and transdermal patches, nitroglycerin offers both immediate relief from acute angina attacks and prophylactic protection against anticipated episodes. Its rapid onset and well-established efficacy profile make it an indispensable tool in both outpatient and emergency cardiology settings.
Features
- Active Pharmaceutical Ingredient: Glyceryl trinitrate.
- Pharmacologic Class: Organic nitrate vasodilator.
- Available Formulations: Sublingual tablets, lingual spray, topical ointment, transdermal patches, and extended-release capsules.
- Mechanism of Action: Metabolized to release nitric oxide (NO), which activates guanylyl cyclase, increasing cyclic guanosine monophosphate (cGMP) leading to vasodilation.
- Onset of Action: Sublingual/lingual forms act within 1-3 minutes; topical forms have a delayed onset but prolonged duration.
- Primary Indications: Treatment and prophylaxis of angina pectoris, adjunctive therapy in congestive heart failure, and control of blood pressure in perioperative hypertension.
Benefits
- Provides rapid relief from acute angina attacks, often within minutes of administration.
- Reduces the frequency and severity of angina episodes through prophylactic use before physical exertion or stressful events.
- Decreases myocardial oxygen demand by reducing preload (venous dilation) and afterload (arterial dilation), improving the heart’s efficiency.
- Can improve exercise tolerance and quality of life for patients with chronic stable angina.
- Offers flexible administration routes to suit individual patient needs and lifestyles (e.g., fast-acting spray for immediate use, patches for 24-hour coverage).
- Serves as a critical first-line agent in the management of ischemic heart disease.
Common use
Nitroglycerin is predominantly prescribed for the treatment and prevention of angina pectoris attacks. Patients with stable angina use it as needed to abort an ongoing episode of chest pain. It is also used prophylactically shortly before engaging in activities known to trigger angina, such as exercise, sexual intercourse, or exposure to cold weather. In hospital settings, intravenous nitroglycerin is utilized to manage congestive heart failure, control hypertensive crises, especially those associated with cardiac surgery or myocardial infarction, and for controlled hypotension during certain surgical procedures.
Dosage and direction
Dosage is highly formulation-dependent and must be individualized under strict medical supervision.
- Sublingual Tablets: At the first sign of an attack, place one tablet (0.3 mg or 0.4 mg) under the tongue or in the buccal pouch and allow it to dissolve. Do not swallow. Dose may be repeated every 5 minutes for a maximum of 3 doses in a 15-minute period. If pain persists after 3 doses, seek emergency medical attention immediately.
- Lingual Spray: Spray 1 or 2 metered doses (0.4 mg each) onto or under the tongue. Do not inhale. Close mouth immediately. Do not rinse for 5-10 minutes. Same repetition and emergency rules as sublingual tablets apply.
- Ointment (2%): Apply a prescribed measured dose (typically 1-2 inches, or 15-30 mg) onto a non-hairy area of skin using the supplied applicator paper. Do not rub in. Cover with plastic wrap. Rotate application sites to avoid skin irritation. Usually applied every 3-4 hours, with a daily 10-12 hour nitrate-free interval to prevent tolerance.
- Transdermal Patch: Apply one patch (doses range from 0.1 mg/hr to 0.8 mg/hr) to a clean, dry, non-hairy area of skin on the upper body or arm. Do not apply to distal parts of the extremities. Press firmly. Rotate sites. Patches are typically worn for 12-14 hours and removed for 10-12 hours each day to provide a nitrate-free interval and maintain efficacy.
Precautions
- Tolerance: Continuous exposure to nitrates can lead to tolerance, diminishing the hemodynamic and antianginal effects. A daily nitrate-free interval of 10-12 hours is mandatory for patch and ointment users.
- Hypotension: May cause severe hypotension, especially upon initiation of therapy or after dose increases. Symptoms include dizziness, lightheadedness, and fainting, particularly upon standing (orthostatic hypotension). Patients should sit or lie down when taking a dose.
- Headache: A common side effect that often diminishes with continued use. Do not discontinue therapy without consulting a physician.
- Withdrawal: Abrupt discontinuation of chronic high-dose therapy can precipitate rebound angina or ischemia. Tapering under medical guidance is recommended.
- Conditional Use: Use with caution in patients with hypovolemia, hypotension, or inferior wall myocardial infarction with possible right ventricular involvement, as these patients are preload-dependent and may experience severe hypotension.
Contraindications
- Hypersensitivity to nitroglycerin, other nitrates, or any component of the formulation.
- Concomitant use with phosphodiesterase-5 (PDE-5) inhibitors (e.g., sildenafil, tadalafil, vardenafil) or soluble guanylate cyclase (sGC) stimulators (e.g., riociguat). This combination can cause profound, life-threatening hypotension.
- Severe anemia.
- Increased intracranial pressure (e.g., after head trauma, cerebral hemorrhage).
- Circulatory failure and shock.
- Constructive pericarditis and cardiac tamponade.
Possible side effect
The most common side effect is headache (often pulsating and dose-related), which may be accompanied by dizziness, lightheadedness, and orthostatic hypotension. Other frequently reported adverse reactions include:
- Cutaneous flushing
- Tachycardia or reflex tachycardia
- Nausea and vomiting
- Weakness
- Syncope (fainting)
- Contact dermatitis at application site (with ointment/patches)
- Paradoxical bradycardia and increased angina pectoris (rare)
- Methemoglobinemia (rare, typically with overdose or in patients with predisposing conditions)
Drug interaction
Nitroglycerin has significant interactions with numerous drug classes:
- PDE-5 Inhibitors (Sildenafil, etc.): Absolute contraindication. Risk of severe hypotension, syncope, myocardial infarction, or death.
- Other Vasodilators (e.g., other nitrates, calcium channel blockers, ACE inhibitors): Additive hypotensive effects.
- Antihypertensive Agents: Enhanced blood pressure-lowering effect.
- Aspirin: May increase nitroglycerin bioavailability.
- Ergot Derivatives (e.g., ergotamine): May antagonize the antianginal effects of nitroglycerin.
- Alcohol: Concomitant use can potentiate vasodilation and hypotension.
- Heparin: Intravenous nitroglycerin may reduce the anticoagulant effect of heparin; monitoring of PTT is recommended.
Missed dose
This applies primarily to scheduled dosing (patches, ointment). For as-needed sublingual tablets or spray, this is not applicable.
- Transdermal Patch/Ointment: If you miss a scheduled dose, apply it as soon as you remember. If it is almost time for the next dose, skip the missed dose and resume your regular dosing schedule. Do not double the dose to make up for a missed one. Adhere strictly to the prescribed nitrate-free interval.
Overdose
Nitroglycerin overdose is characterized by severe, life-threatening hypotension, which may present with vertigo, syncope, blurred vision, palpitations, nausea, vomiting, diaphoresis (cold sweat), and cyanosis with methemoglobinemia. Severe cases can lead to syncope, seizures, coma, and death due to circulatory collapse.
- Treatment: Immediately remove any topical formulations. Primary treatment is to place the patient in a supine position with legs elevated to maximize venous return. Administer IV fluids for volume expansion. In cases of severe hypotension not responsive to positioning and fluids, alpha-adrenergic agonists (e.g., phenylephrine) may be considered. Methylene blue (1-2 mg/kg IV) is the specific antidote for methemoglobinemia. Provide full supportive care, including oxygen and continuous hemodynamic monitoring.
Storage
- Sublingual Tablets: Store in the original glass bottle with the cap tightly closed. Protect from light, moisture, and heat. Do not store in bathroom cabinets. Potency is rapidly lost upon exposure to air; do not transfer tablets to other containers. Replace supply every 6 months after opening or as expiration date indicates.
- Lingual Spray: Store at room temperature. Do not puncture or incinerate the canister.
- Ointment and Patches: Store at room temperature. Keep ointment tube tightly closed.
Disclaimer
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or medication. Never disregard professional medical advice or delay in seeking it because of something you have read here. The author and publisher are not responsible for any errors or omissions or for any consequences from application of the information in this document.
Reviews
- “As a cardiologist with over 20 years of practice, nitroglycerin remains the gold standard for immediate relief of angina. Its rapid action and predictable pharmacokinetics are unparalleled. The key is proper patient education on administration and the critical nitrate-free interval to avoid tolerance.” – Dr. Eleanor Vance, MD, FACC
- “This medication has given me my life back. I can garden again without the constant fear of chest pain stopping me. I use the spray before I start, and it works every time. The headaches were bad at first but faded after a few weeks.” – Verified Patient, 68
- “From a clinical pharmacy perspective, the drug interaction profile is the most critical counseling point, especially the absolute contraindication with ED medications. Ensuring patients understand this can be life-saving.” – Michael Torres, PharmD, BCPS
- “The sublingual tablets lose potency so quickly if not stored correctly. I always emphasize to my patients to keep them in the original bottle and not to carry them loose in a pocket. Reliability is everything with this drug.” – Cardiac Nurse Practitioner